Natco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO, and what generic and branded alternatives to NATCO drugs are available?
NATCO has thirty-seven approved drugs.
There are three tentative approvals on NATCO drugs.
Summary for Natco
US Patents: | 0 |
Tradenames: | 34 |
Ingredients: | 34 |
NDAs: | 37 |
Patent Litigation for Natco: | See patent lawsuits for Natco |
Drugs and US Patents for Natco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco Pharma Ltd | LAPATINIB DITOSYLATE | lapatinib ditosylate | TABLET;ORAL | 203007-001 | Sep 29, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Natco | BUDESONIDE | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 206724-001 | Nov 23, 2016 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Natco Pharma Ltd | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 203478-001 | Jul 1, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.